AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.
about
Knockdown of anterior gradient 2 expression extenuates tumor-associated phenotypes of SNU-478 ampulla of Vater cancer cells.Dicer regulates differentiation and viability during mouse pancreatic cancer initiationA proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types.Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinomaNew Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in MiceThe metastasis-inducing protein AGR2 is O-glycosylated upon secretion from mammary epithelial cells.The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarkerComplex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse modelQuantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesisMUC1 (CD227): a multi-tasked molecule.T cell optimization for the treatment of pancreatic cancer.Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.Engineering a synthetic cell panel to identify signalling components reprogrammed by the cell growth regulator anterior gradient-2.Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line.
P2860
Q34492618-77EC7A33-40AC-4F04-9B13-FE80BC2DFFAAQ35161464-6CFE7475-AD1B-4694-B4FB-0A5E24C6D471Q35688354-4F0C3EBF-6FE1-4FAA-89F5-018AD860DB8BQ35799421-F472FBDE-1C08-4486-B867-3576FC350288Q35832228-C5076863-8B66-4713-ABF3-156D14FDFACDQ36246425-A7677966-7367-4E83-BE0E-EF3BA565D078Q36455613-ABD7E7F2-91D8-4C7C-8B2A-22ABCDCE08C6Q36621607-BCA9A616-766E-4C83-97ED-CDBD097B6037Q36903188-FF186DF3-4F83-420C-9A52-9594321AE9BAQ37205853-17D33633-C2E5-4B6D-B93D-EBB8C88E2637Q37210782-2A298A1A-2E77-4C20-93B5-BE6E40A17339Q37564481-4B6B9A81-F3F1-415A-AF56-BA56C9341536Q38570769-682355A5-58DF-4E12-8FA1-D2984B0BA10DQ38638035-28A8F1F5-3ACA-4608-96DB-B340EAFDC043Q38662233-72B999CF-1BA9-4A5B-88A5-2BF31AC4FD7AQ39006763-17AB9099-32AB-4A60-990D-6BCBD055A836Q41412520-1E34F49A-C264-4BDC-BB69-607F2F45129BQ41651528-956F89AF-C2A2-4A5E-9C06-922A512E6D68Q41931284-D07E2AC0-06A5-4B76-B95D-364B62666CC3Q50234490-1F5A67D8-6708-4315-9BF7-33506A0E8A94
P2860
AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
AGR2 is a SMAD4-suppressible g ...... tic intraepithelial neoplasia.
@ast
AGR2 is a SMAD4-suppressible g ...... tic intraepithelial neoplasia.
@en
type
label
AGR2 is a SMAD4-suppressible g ...... tic intraepithelial neoplasia.
@ast
AGR2 is a SMAD4-suppressible g ...... tic intraepithelial neoplasia.
@en
prefLabel
AGR2 is a SMAD4-suppressible g ...... tic intraepithelial neoplasia.
@ast
AGR2 is a SMAD4-suppressible g ...... tic intraepithelial neoplasia.
@en
P2093
P2860
P356
P1433
P1476
AGR2 is a SMAD4-suppressible g ...... tic intraepithelial neoplasia.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.394
P407
P577
2012-09-03T00:00:00Z